Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ‰2 Years of Follow-Up
- Thomas Powles
- , Se Hoon Park
- , Claudia Caserta
- , Begoña P. Valderrama
- , Howard Gurney
- , Anders Ullén
- , Yohann Loriot
- , Srikala S. Sridhar
- , Cora N. Sternberg
- , Joaquim Bellmunt
- , Jeanny B. Aragon-Ching
- , Jing Wang
- , Bo Huang
- , Robert J. Laliberte
- , Alessandra Di Pietro
- , Petros Grivas
- Queen Mary University of London
- Azienda Ospedaliera S. Maria di Terni
- Hospital Universitario Virgen del Rocio
- Macquarie University
- Karolinska Institutet
- Gustave Roussy
- Princess Margaret Cancer Centre
- Cornell University
- Harvard University
- Inova Schar Cancer Institute
- Pfizer
- University of Washington
Research output: Contribution to journal › Article › peer-review
177
Link opens in a new tab
Scopus
citations